Biểu đồ giá cổ phiếu TCBPY
TCBPY Giá
TC Biopharm (Holdings) PLC
$0
-8.33%
$0
Khi đóng cửa: May 22, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: May 22, 20:00:00 GMT-4
Quay lại
TC Biopharm (Holdings) PLC (TCBPY) Giá
Thống kê chính
Giá đóng cửa trước
$0.006
Giá mở cửa
$0.041
Phạm vi ngày
$0.0055 - $0.041
Phạm vi 52 tuần
$0.005 - $0.4
Khối lượng
31.2K
Khối lượng trung bình
12.4K
Tỷ suất cổ tức
--
EPS (TTM)
-7.34
Vốn hóa thị trường
$56.4K
TCBPY là gì?
TC BioPharm (Holdings) plc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T (GD-T) cell therapies for the treatment of cancer with human efficacy data in acute myeloid leukemia (AML). The Company is conducting two investigator-initiated clinical trials for its unmodified GD-T cell product line - phase IIb/III pivotal trial in treatment of AML using its allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product candidate, OmnImmune is an unmodified allogeneic GD-T cell product, being initially used for the treatment of AML. Its pre-clinical stage program is focused on developing CAR-modified allogeneic GD-T cell products targeting solid and hematological indications. It has an Israeli patent and Japanese patent applications covering the method of preparing and using GD-T cells in the allogeneic treatment of subjects suffering from viral, fungal and protozoal infections or cancer.
